"SEER Program" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A cancer registry mandated under the National Cancer Act of 1971 to operate and maintain a population-based cancer reporting system, reporting periodically estimates of cancer incidence and mortality in the United States. The Surveillance, Epidemiology, and End Results (SEER) Program is a continuing project of the National Cancer Institute of the National Institutes of Health. Among its goals, in addition to assembling and reporting cancer statistics, are the monitoring of annual cancer incident trends and the promoting of studies designed to identify factors amenable to cancer control interventions. (From National Cancer Institute, NIH Publication No. 91-3074, October 1990)
Descriptor ID |
D018426
|
MeSH Number(s) |
E05.318.308.970.725 N04.452.859.819.725 N05.715.360.300.715.700.725 N06.850.520.308.970.725
|
Concept/Terms |
SEER Program- SEER Program
- Program, SEER
- SEER Program (National Cancer Institute (U.S.))
- Surveillance, Epidemiology, and End Results Program
|
Below are MeSH descriptors whose meaning is more general than "SEER Program".
Below are MeSH descriptors whose meaning is more specific than "SEER Program".
This graph shows the total number of publications written about "SEER Program" by people in this website by year, and whether "SEER Program" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 0 | 1 | 1 |
2002 | 0 | 1 | 1 |
2003 | 0 | 1 | 1 |
2004 | 1 | 1 | 2 |
2005 | 0 | 2 | 2 |
2006 | 0 | 5 | 5 |
2007 | 0 | 7 | 7 |
2008 | 2 | 2 | 4 |
2009 | 2 | 13 | 15 |
2010 | 0 | 10 | 10 |
2011 | 2 | 6 | 8 |
2012 | 0 | 7 | 7 |
2013 | 1 | 2 | 3 |
2014 | 1 | 2 | 3 |
2015 | 0 | 5 | 5 |
2016 | 0 | 9 | 9 |
2017 | 2 | 7 | 9 |
2018 | 1 | 3 | 4 |
2019 | 0 | 2 | 2 |
2021 | 0 | 3 | 3 |
2024 | 1 | 4 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "SEER Program" by people in Profiles.
-
Leslie Salewon M, Pathak R, Dooley WC, Squires RA, Rui H, Chervoneva I, Tanaka T. Surgical delay-associated mortality risk varies by subtype in loco-regional breast cancer patients in SEER-Medicare. Breast Cancer Res. 2024 Dec 30; 26(1):191.
-
Peleman J, Ruan M, Dey T, Chiang S, Dilger A, Mitchell MB, Jung YS, Ramanathan M, Mady L, Yu S, Cramer J, Lee SE. Air pollution exposure and head and neck cancer incidence. Sci Rep. 2024 11 12; 14(1):26998.
-
Kim HJ, Griffith KA, Ricciardi R, Le D, Glenn A, Cameron V, Juon HS. Exploring disparities in healthcare utilization, cancer care experience, and beliefs about cancer among asian and hispanic cancer survivors. Support Care Cancer. 2024 Oct 30; 32(11):756.
-
DuBois TD, Henry KA, Siegel SD, Lynch SM. Geographic Disparities in Cancer Incidence in the US Population Aged 20 to 49 Years, 2016-2020. Prev Chronic Dis. 2024 May 09; 21:E32.
-
Nikita N, Gandhi K, Keith SW, Sharma S, Kelly WK, Lu-Yao G. The rates of septicemia in older adults with prostate cancer treated with abiraterone or enzalutamide: A population-based study. J Geriatr Oncol. 2024 Jun; 15(5):101773.
-
Sesti J, Almaz B, Bell J, Nguyen A, Bamboat Z, Lackey A, Langan RC, Turner AL, Hilden P, Paul S. Impact of postoperative complications on long-term survival after esophagectomy in older adults: A SEER-Medicare analysis. J Surg Oncol. 2021 Oct; 124(5):751-766.
-
Hossain MJ, Xiao W, Tayeb M, Khan S. Epidemiology and prognostic factors of pediatric brain tumor survival in the US: Evidence from four decades of population data. Cancer Epidemiol. 2021 06; 72:101942.
-
Holmes L, Williams MA, Halloran DR, Benson JA, Bafford NT, Parson KV, Dabney K, Berice BN. Social gradient predicts survival disadvantage of African Americans/Black children with lymphoma. J Natl Med Assoc. 2021 Aug; 113(4):414-427.
-
Morgan RL, Eguchi MM, Mueller AC, Daugherty SL, Amini A, Karam SD. Imaging at diagnosis impacts cancer-specific survival among patients with cancer of the oropharynx. Cancer. 2019 08 15; 125(16):2794-2802.
-
Gupta A, Stokes W, Eguchi M, Hararah M, Amini A, Mueller A, Morgan R, Bradley C, Raben D, McDermott J, Karam SD. Statin use associated with improved overall and cancer specific survival in patients with head and neck cancer. Oral Oncol. 2019 03; 90:54-66.